98 related articles for article (PubMed ID: 27125403)
1. METCAM/MUC18 promoted tumorigenesis of human breast cancer SK-BR-3 cells in a dosage-specific manner.
Huang CY; Wu GJ
Taiwan J Obstet Gynecol; 2016 Apr; 55(2):202-12. PubMed ID: 27125403
[TBL] [Abstract][Full Text] [Related]
2. METCAM/MUC18 augments migration, invasion, and tumorigenicity of human breast cancer SK-BR-3 cells.
Zeng G; Cai S; Liu Y; Wu GJ
Gene; 2012 Jan; 492(1):229-38. PubMed ID: 22057013
[TBL] [Abstract][Full Text] [Related]
3. METCAM/MUC18 is a novel tumor and metastasis suppressor for the human ovarian cancer SKOV3 cells.
Wu GJ; Zeng GF
BMC Cancer; 2016 Feb; 16():136. PubMed ID: 26906545
[TBL] [Abstract][Full Text] [Related]
4. Enforced Expression of METCAM/MUC18 Decreases In Vitro Motility and Invasiveness and Tumorigenesis and In Vivo Tumorigenesis of Human Ovarian Cancer BG-1 Cells.
Wu GJ
Adv Exp Med Biol; 2021; 1330():125-137. PubMed ID: 34339034
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of METCAM/MUC18 promotes motility, invasion, and tumorigenesis of human breast cancer cells.
Zeng GF; Cai SX; Wu GJ
BMC Cancer; 2011 Mar; 11():113. PubMed ID: 21450088
[TBL] [Abstract][Full Text] [Related]
6. METCAM/MUC18 Plays a Tumor Suppressor Role in the Development of Nasopharyngeal Carcinoma Type I.
Liu YC; Chen YJ; Wu GJ
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362174
[TBL] [Abstract][Full Text] [Related]
7. METCAM/MUC18 Decreases the Malignant Propensity of Human Ovarian Carcinoma Cells.
Wu GJ
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30274262
[TBL] [Abstract][Full Text] [Related]
8. Ectopical expression of human MUC18 increases metastasis of human prostate cancer cells.
Wu GJ; Peng Q; Fu P; Wang SW; Chiang CF; Dillehay DL; Wu MW
Gene; 2004 Mar; 327(2):201-13. PubMed ID: 14980717
[TBL] [Abstract][Full Text] [Related]
9. Enforced expression of MCAM/MUC18 increases in vitro motility and invasiveness and in vivo metastasis of two mouse melanoma K1735 sublines in a syngeneic mouse model.
Wu GJ; Fu P; Wang SW; Wu MW
Mol Cancer Res; 2008 Nov; 6(11):1666-77. PubMed ID: 19010815
[TBL] [Abstract][Full Text] [Related]
10. Enforced expression of METCAM/MUC18 increases tumorigenesis of human prostate cancer LNCaP cells in nude mice.
Wu GJ; Wu MW; Wang C; Liu Y
J Urol; 2011 Apr; 185(4):1504-12. PubMed ID: 21334670
[TBL] [Abstract][Full Text] [Related]
11. Frequent and increased expression of human METCAM/MUC18 in cancer tissues and metastatic lesions is associated with the clinical progression of human ovarian carcinoma.
Wu GJ; Dickerson EB
Taiwan J Obstet Gynecol; 2014 Dec; 53(4):509-17. PubMed ID: 25510693
[TBL] [Abstract][Full Text] [Related]
12. Significance of expression of human METCAM/MUC18 in nasopharyngeal carcinomas and metastatic lesions.
Lin JC; Chiang CF; Wang SW; Wang WY; Kwan PC; Wu GJ
Asian Pac J Cancer Prev; 2014; 15(1):245-52. PubMed ID: 24528033
[TBL] [Abstract][Full Text] [Related]
13. Ectopic expression of MCAM/MUC18 increases in vitro motility and invasiveness, but decreases in vivo tumorigenesis and metastasis of a mouse melanoma K1735-9 subline in a syngeneic mouse model.
Wu GJ
Clin Exp Metastasis; 2016 Dec; 33(8):817-828. PubMed ID: 27510563
[TBL] [Abstract][Full Text] [Related]
14. METCAM/MUC18 is a new early diagnostic biomarker for the malignant potential of prostate cancer: Validation with Western blot method, enzyme-linked immunosorbent assay and lateral flow immunoassay.
Pong YH; Su YR; Lo HW; Ho CK; Hsieh CC; Chu CT; Chen-Yang YW; Tsai VFS; Wu JC; Wu GJ
Cancer Biomark; 2020; 27(3):377-387. PubMed ID: 31958077
[TBL] [Abstract][Full Text] [Related]
15. Fully human antibodies to MCAM/MUC18 inhibit tumor growth and metastasis of human melanoma.
Mills L; Tellez C; Huang S; Baker C; McCarty M; Green L; Gudas JM; Feng X; Bar-Eli M
Cancer Res; 2002 Sep; 62(17):5106-14. PubMed ID: 12208768
[TBL] [Abstract][Full Text] [Related]
16. MTDH mediates trastuzumab resistance in HER2 positive breast cancer by decreasing PTEN expression through an NFκB-dependent pathway.
Du C; Yi X; Liu W; Han T; Liu Z; Ding Z; Zheng Z; Piao Y; Yuan J; Han Y; Xie M; Xie X
BMC Cancer; 2014 Nov; 14():869. PubMed ID: 25417825
[TBL] [Abstract][Full Text] [Related]
17. Validating METCAM/MUC18 as a Novel Biomarker to Predict the Malignant Potential of Prostate Cancer at an Early Stage by Using a Modified Gold Nanoparticles-Based Lateral Flow Immunoassay.
Wu JC; Chuang YH; Wei YC; Hsieh CC; Pong YH; Su YR; Tsai VF; Wu GJ
Diagnostics (Basel); 2021 Mar; 11(3):. PubMed ID: 33806580
[TBL] [Abstract][Full Text] [Related]
18. A fully human antimelanoma cellular adhesion molecule/MUC18 antibody inhibits spontaneous pulmonary metastasis of osteosarcoma cells in vivo.
McGary EC; Heimberger A; Mills L; Weber K; Thomas GW; Shtivelband M; Lev DC; Bar-Eli M
Clin Cancer Res; 2003 Dec; 9(17):6560-6. PubMed ID: 14695161
[TBL] [Abstract][Full Text] [Related]
19. Mel-18 negatively regulates INK4a/ARF-independent cell cycle progression via Akt inactivation in breast cancer.
Lee JY; Jang KS; Shin DH; Oh MY; Kim HJ; Kim Y; Kong G
Cancer Res; 2008 Jun; 68(11):4201-9. PubMed ID: 18519679
[TBL] [Abstract][Full Text] [Related]
20. Restoration of Arpin suppresses aggressive phenotype of breast cancer cells.
Li Y; Qiu J; Pang T; Guo Z; Su Y; Zeng Q; Zhang X
Biomed Pharmacother; 2017 Aug; 92():116-121. PubMed ID: 28531800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
